{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:22Z","timestamp":1790835622877,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T08:16:11Z","timestamp":1507968971000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Agonistic antibodies in systemic sclerosis"],"prefix":"10.1016","volume":"195","author":[{"given":"Gianluca","family":"Moroncini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Svegliati Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.10.007_bib0005","first-page":"753","article-title":"Human antibodies to vascular endothelium","volume":"9","author":"Lindqvist","year":"1971","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0049-0172(97)80010-8","article-title":"Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies","volume":"27","author":"Belizna","year":"1997","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.007_bib0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","article-title":"Antiendothelial cell antibodies: useful markers of systemic sclerosis","volume":"102","author":"Salojin","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0020","first-page":"527","article-title":"Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0030","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.0030002","article-title":"Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach","volume":"3","author":"Lunardi","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clim.2006.02.006","article-title":"Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B)","volume":"120","author":"Servettaz","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2249.1996.d01-867.x","article-title":"Milford Ward A, Greaves M, Hughes P. Antibodies to membranes of endothelial cells and fibroblasts in scleroderma","volume":"106","author":"Hill","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cei.12166","article-title":"Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension?","volume":"174","author":"Arends","year":"2013","journal-title":"Clin Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2013.05.002","article-title":"Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascades","volume":"59","author":"Wolf","year":"2013","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0055","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.007_bib0060","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.11179","article-title":"In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay","volume":"48","author":"Worda","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.007_bib0065","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.4049\/jimmunol.174.9.5740","article-title":"Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis","volume":"174","author":"Laplante","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0070","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.175.5.1227","article-title":"Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts","volume":"175","author":"Yamakage","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0075","doi-asserted-by":"crossref","first-page":"36474","DOI":"10.1074\/jbc.M502851200","article-title":"Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1\/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts","volume":"280","author":"Svegliati","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.10.007_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1755-1536-4-8","article-title":"Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts","volume":"4","author":"Smaldone","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.imlet.2017.10.007_bib0085","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","article-title":"Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis","volume":"60","author":"Classen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.007_bib0095","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","article-title":"Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera","volume":"60","author":"Loizos","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.007_bib0100","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/art.27209","article-title":"Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al","volume":"60","author":"Gabrielli","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.007_bib0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.24364","article-title":"Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology","volume":"60","author":"Dragun","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.10.007_bib0110","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/art.39125","article-title":"Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor alpha autoantibodies in systemic sclerosis","volume":"67","author":"Moroncini","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ab.2017.04.011","article-title":"Characterization of binding and quantification of human autoantibodies to PDGFRalpha using a biosensor-based approach","volume":"528","author":"Moroncini","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.imlet.2017.10.007_bib0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2007.11.012","article-title":"Integrating immunity: the immunculus and self-reactivity","volume":"30","author":"Poletaev","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2017.10.007_bib0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","article-title":"B cell epitope spreading: mechanisms and contribution to autoimmune diseases","volume":"163","author":"Cornaby","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2017.10.007_bib0130","first-page":"S160","article-title":"Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab","volume":"33","author":"Fraticelli","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0135","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/art.39728","article-title":"Induction of scleroderma fibrosis in skin-humanized mice by administration of anti-platelet-derived growth factor receptor agonistic autoantibodies","volume":"68","author":"Luchetti","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0140","first-page":"75","article-title":"Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function In vitro","volume":"8","author":"Svegliati","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.10.007_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2009.05.004","article-title":"Is preeclampsia an autoimmune disease","volume":"133","author":"Xia","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0155","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00004872-200018070-00017","article-title":"Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension","volume":"18","author":"Fu","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.imlet.2017.10.007_bib0160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","article-title":"Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases","volume":"36","author":"Wallukat","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann. Rheum Dis."},{"key":"10.1016\/j.imlet.2017.10.007_bib0175","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0180","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Gunther","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.10.007_bib0185","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.10.007_bib0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI117395","article-title":"Antimyenteric neuronal antibodies in scleroderma","volume":"94","author":"Howe","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.10.007_bib0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-2143(99)90184-1","article-title":"Myenteric neuronal antibodies in scleroderma: passive transfer evokes alterations in intestinal myoelectric activity in a rat model","volume":"133","author":"Eaker","year":"1999","journal-title":"J. Lab Clin. Med."},{"key":"10.1016\/j.imlet.2017.10.007_bib0200","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/gast.2002.36057","article-title":"Antibody-mediated gastrointestinal dysmotility in scleroderma","volume":"123","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2017.10.007_bib0205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2008.096545","article-title":"Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility","volume":"68","author":"Kawaguchi","year":"2009","journal-title":"Ann. Rheum Dis."},{"key":"10.1016\/j.imlet.2017.10.007_bib0210","doi-asserted-by":"crossref","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","article-title":"Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells","volume":"297","author":"Singh","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cei.12324","article-title":"A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera","volume":"177","author":"Preuss","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2017.10.007_bib0220","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann. Rheum Dis."},{"key":"10.1016\/j.imlet.2017.10.007_bib0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0300-9475.2004.01395.x","article-title":"Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome","volume":"59","author":"Cavill","year":"2004","journal-title":"Scand. J. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T05:28:08Z","timestamp":1547702888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817303644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"alternative-id":["S0165247817303644"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.10.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agonistic antibodies in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}